Abstract
Identification of secreted proteins of lung cancer could provide new candidates of serum biomarkers for cancer diagnosis or targets for therapeutic intervention. In this study, we developed a novel strategy that combined functional monoclonal antibody library screening technique and mass spectrometry to identify functional secreted proteins. BALB/c mice were immunized with cancer cells isolated from fresh human lung cancer tissues. The monoclonal antibody library containing 1160 mAbs was established with the mouse spleen cells, whose serum had most anti-proliferative effect on lung cancer cells. Monoclonal antibodies were subjected to an immunoreactive and functional screen and monoclonal antibodies that reacted strongly with secreted proteins in condition medium and lung cancer tissues with high inhibotion of cell proliferation were selected. Antigens that recognized by antibodies were obtained by immunoprecipitation and then identified by mass spectrometry. Mac-2-binding protein (Mac-2BP), the antigen of 13H3 antibody, was identified using this approach. Functional studies demonstrated that the 13H3 antibody suppressed lung cancer cell lines ANIP-973 and A549 proliferation in vitro and inhibit ANIP973 xenograft tumors growth in vivo by inducing cell-cycle arrest at G1 phase, with up-regulation of p27 and down-regulation of cyclin D1. Moreover, the serum level of Mac-2BP was significantly higher in lung cancer patients than healthy controls. At a cutoff value of 6 μg/ml, Mac-2BP might be a diagnostic biomarker of lung cancer, especially for SCLC. Mac-2BP concentrations of 6 μg/ml or higher was associated with poor overall survival in univariate analysis, and was an independent predictor in the multivariate COX analysis. Together, these results firstly demonstrated that Mac-2BP can be used as a therapeutic target and potential biomarker for lung cancer. Our strategy is feasible, which may facilitate the identification of novel secreted biomarkers of lung cancer.
Highlights
TNM stagelarge cell lung cancer (LCLC) SCC SCC SCC SCC SCC SCC SCC SCC AC AC AC AC AC AC AC AC AC SCLC SCLC cer-associated secreted functional biomarkers
From the ‡State Key Laboratory of Molecular Oncology, Cancer Institute (Hospital), Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; §Department of Cell and Molecular Biology, Cancer Institute (Hospital), Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; ¶Department of Hematology and Oncology, Children’s Hospital of Soochow University, Suzhou, China; ʈState Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences
The Functional Antibody Library Was Established by Immunizing Mouse With Lung Cancer Cells From Lung Cancer Patients—We used lung cancer cells, which were isolated from 20 fresh primary lung cancer tissues, for the immunization of five mice
Summary
LCLC SCC SCC SCC SCC SCC SCC SCC SCC AC AC AC AC AC AC AC AC AC SCLC SCLC cer-associated secreted functional biomarkers. A monoclonal antibody library was established by immunizing mice with lung cancer cells isolated from carcinoma tissues. Monoclonal antibodies that reacted with secreted proteins from human lung cancer cells and recognized lung cancer tissues were selected. The corresponding antigens were identified by immunoprecipitation and mass spectrometry. Using this strategy we successfully identified Mac-2BP as a potential therapeutic target and biomarker for lung cancer
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
